WEBSITE BSE:524582 NSE : TIRUPATI STA 18 May, 12:50
Market Cap ₹0 Cr.
Stock P/E 25.8
P/B 3.1
Current Price ₹174
Book Value ₹ 55.3
Face Value 10
52W High ₹207.3
Dividend Yield 0%
52W Low ₹ 65
Tirupati Starch & Chemicals Limited (TSCL) is a leading company in the Wet Corn Process industry, located at Village-Sejwaya Ghatabillod, near Indore, Madhya Pradesh. Established in 1985, TSCL began production of normal starch, X-pharma grade starch, and dextrines in 1989. The company expanded in 1996, producing Dextrose Monohydrate & Dextrose Anhydrous IP/BP/USP.The company’s premises are designed to meet the specific requirements of its operations, with R.C.C structures and industrial flooring in all process areas.TSCL was conceived and promoted by Dr. Damodar Modi, who practiced medicine in Iran for 8 years under Indian Government deputation before starting the company. He has over 27 years of experience in the specialty starch industry and oversees production and sales of Dextrose. Other key figures include Mr. Yogesh Agrawal, who has been with TSCL for 20 years and manages the Sales division, and Mr. B.K. Goyal, who oversees the Purchase of Maize.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 32 | 52 | 57 | 59 | 64 | 79 | 84 | 90 | 93 | 86 |
Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 0 | 0 |
Total Income | 32 | 52 | 57 | 59 | 64 | 79 | 84 | 92 | 93 | 86 |
Total Expenditure | 35 | 49 | 53 | 53 | 61 | 75 | 80 | 83 | 88 | 79 |
Operating Profit | -3 | 3 | 3 | 6 | 3 | 4 | 5 | 9 | 5 | 8 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Depreciation | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -5 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 1 | 4 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Profit After Tax | -5 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 1 | 4 |
Adjustments | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -5 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 1 | 4 |
Adjusted Earnings Per Share | -8 | 1.9 | 2.2 | 4.8 | 0.7 | 2.1 | 3 | 6.2 | 1.1 | 4.9 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 59 | 61 | 59 | 158 | 175 | 199 | 227 | 272 | 200 | 318 | 364 | 353 |
Other Income | 1 | 1 | 1 | 1 | 5 | 1 | 1 | 1 | 0 | 2 | 1 | 1 |
Total Income | 59 | 62 | 60 | 159 | 179 | 200 | 228 | 272 | 200 | 320 | 365 | 355 |
Total Expenditure | 58 | 58 | 55 | 153 | 171 | 189 | 216 | 264 | 191 | 299 | 343 | 330 |
Operating Profit | 1 | 4 | 4 | 6 | 9 | 11 | 11 | 9 | 9 | 21 | 22 | 27 |
Interest | 1 | 1 | 1 | 6 | 5 | 4 | 3 | 2 | 3 | 6 | 8 | 7 |
Depreciation | 1 | 1 | 2 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | 2 | 1 | -5 | 0 | 2 | 4 | 2 | 1 | 9 | 8 | 12 |
Provision for Tax | -0 | 0 | 2 | -3 | -1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
Profit After Tax | -1 | 1 | -1 | -2 | 1 | 2 | 3 | 1 | 1 | 8 | 7 | 11 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -1 | 1 | -1 | -2 | 1 | 2 | 3 | 1 | 1 | 8 | 7 | 11 |
Adjusted Earnings Per Share | -1.3 | 1.9 | -2 | -2.5 | 1.9 | 2.9 | 5.3 | 1.9 | 1.5 | 11.8 | 8.1 | 15.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 14% | 10% | 13% | 20% |
Operating Profit CAGR | 5% | 35% | 15% | 36% |
PAT CAGR | -13% | 91% | 28% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 166% | 61% | 39% | 39% |
ROE Average | 16% | 15% | 14% | 6% |
ROCE Average | 13% | 12% | 12% | 9% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 12 | 15 | 13 | 12 | 13 | 17 | 21 | 22 | 28 | 36 | 46 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 15 | 28 | 27 | 37 | 38 | 12 | 14 | 14 | 50 | 68 | 64 |
Other Non-Current Liabilities | 1 | 1 | 3 | 4 | 20 | 40 | 46 | 1 | 10 | 3 | 4 |
Total Current Liabilities | 9 | 13 | 39 | 51 | 35 | 38 | 58 | 102 | 46 | 51 | 55 |
Total Liabilities | 36 | 57 | 82 | 105 | 105 | 108 | 138 | 140 | 133 | 158 | 169 |
Fixed Assets | 7 | 6 | 61 | 59 | 64 | 65 | 60 | 55 | 71 | 61 | 55 |
Other Non-Current Assets | 10 | 33 | 1 | 5 | 1 | 1 | 11 | 20 | 16 | 26 | 53 |
Total Current Assets | 19 | 18 | 20 | 41 | 40 | 42 | 67 | 65 | 47 | 71 | 61 |
Total Assets | 36 | 57 | 82 | 105 | 105 | 108 | 138 | 140 | 133 | 158 | 169 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 1 | 3 | 17 | -4 | 14 | 33 | 5 | 12 | -35 | -1 | 23 |
Cash Flow from Investing Activities | -13 | -21 | -20 | -6 | -5 | -5 | -9 | -9 | -6 | -6 | -25 |
Cash Flow from Financing Activities | 13 | 18 | 3 | 10 | -8 | -28 | 4 | -3 | 41 | 7 | 9 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | -0 | 8 |
Closing Cash & Cash Equivalent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -1.35 | 1.95 | -1.96 | -2.49 | 1.87 | 2.91 | 5.32 | 1.89 | 1.47 | 11.8 | 8.12 |
CEPS(Rs) | 0.27 | 3.67 | 0.82 | 4.89 | 9.38 | 10.62 | 13.22 | 9.8 | 8.78 | 20.16 | 15.07 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 19.76 | 21.71 | 19.53 | 17.04 | 21.37 | 28.65 | 33.96 | 35.85 | 39.68 | 51.49 | 56.88 |
Core EBITDA Margin(%) | 0.92 | 4.65 | 6.33 | 3.37 | 2.18 | 4.43 | 4.77 | 2.96 | 4.58 | 6.11 | 5.77 |
EBIT Margin(%) | 0.33 | 4.13 | 4.44 | 1.03 | 2.69 | 2.89 | 2.92 | 1.44 | 2.09 | 4.81 | 4.39 |
Pre Tax Margin(%) | -1.54 | 2.46 | 2.16 | -2.93 | 0.02 | 1.02 | 1.81 | 0.57 | 0.53 | 2.97 | 2.09 |
PAT Margin (%) | -1.33 | 1.85 | -2.01 | -0.96 | 0.62 | 0.81 | 1.43 | 0.42 | 0.51 | 2.6 | 1.8 |
Cash Profit Margin (%) | 0.26 | 3.48 | 0.84 | 1.88 | 3.11 | 2.95 | 3.54 | 2.2 | 3.08 | 4.43 | 3.35 |
ROA(%) | -2.82 | 2.55 | -1.72 | -1.62 | 1.09 | 1.66 | 2.63 | 0.83 | 0.75 | 5.68 | 4.02 |
ROE(%) | -6.6 | 9.4 | -9.49 | -13.6 | 9.76 | 11.63 | 16.99 | 5.41 | 4.13 | 25.9 | 16.01 |
ROCE(%) | 0.78 | 6.23 | 4.86 | 2.69 | 7.78 | 12 | 15.2 | 8.92 | 6.61 | 15.68 | 12.85 |
Receivable days | 26.71 | 26.12 | 36.63 | 30.3 | 35.82 | 31.5 | 46.9 | 43.74 | 47.32 | 31.48 | 31.81 |
Inventory Days | 35.05 | 40.32 | 58.41 | 33.41 | 32.32 | 23.44 | 25.3 | 31.73 | 40.06 | 27.48 | 23.27 |
Payable days | 15.21 | 24.18 | 125.11 | 81.83 | 68.3 | 53.19 | 72.44 | 115.11 | 162.21 | 56.69 | 38.79 |
PER(x) | 0 | 2.58 | 0 | 0 | 9.13 | 13.83 | 6.78 | 6.75 | 23.55 | 5.68 | 7.82 |
Price/Book(x) | 0.3 | 0.23 | 0.62 | 1.18 | 0.8 | 1.41 | 1.06 | 0.36 | 0.87 | 1.3 | 1.12 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.4 | 0.68 | 0.85 | 0.42 | 0.34 | 0.25 | 0.19 | 0.11 | 0.39 | 0.39 | 0.37 |
EV/Core EBITDA(x) | 19.85 | 11.31 | 11.69 | 10.82 | 6.92 | 4.5 | 3.84 | 3.35 | 8.42 | 5.81 | 6.16 |
Net Sales Growth(%) | 3 | 4.29 | -3.33 | 167.13 | 10.51 | 13.96 | 14.19 | 19.5 | -26.38 | 59.1 | 14.47 |
EBIT Growth(%) | -82.59 | 1193.37 | -0.91 | -38.37 | 205.59 | 28.34 | 4.38 | -41.02 | 6.69 | 266.5 | 4.39 |
PAT Growth(%) | -407.84 | 244.45 | -200.35 | -27.07 | 175.36 | 55.28 | 82.76 | -64.5 | -10.82 | 705.7 | -20.51 |
EPS Growth(%) | -407.84 | 244.44 | -200.35 | -27.07 | 175.37 | 55.28 | 82.75 | -64.5 | -22.38 | 705.71 | -31.23 |
Debt/Equity(x) | 1.71 | 2.57 | 3.15 | 4.45 | 3.8 | 1.49 | 1.12 | 1.01 | 1.97 | 2.13 | 1.95 |
Current Ratio(x) | 2.09 | 1.37 | 0.52 | 0.81 | 1.14 | 1.1 | 1.17 | 0.64 | 1.01 | 1.39 | 1.11 |
Quick Ratio(x) | 1.32 | 0.81 | 0.23 | 0.47 | 0.71 | 0.76 | 0.85 | 0.36 | 0.68 | 0.75 | 0.86 |
Interest Cover(x) | 0.18 | 2.47 | 1.94 | 0.26 | 1.01 | 1.54 | 2.64 | 1.66 | 1.34 | 2.61 | 1.91 |
Total Debt/Mcap(x) | 5.61 | 12.33 | 5.72 | 4.33 | 4.75 | 1.06 | 1.06 | 2.84 | 2.26 | 1.63 | 1.75 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 63.01 | 63.03 | 63 | 63 | 67.98 | 67.99 | 67.99 | 67.99 | 68.05 | 73.04 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.35 | 0.35 | 0.35 | 0.35 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.26 |
Public | 36.64 | 36.62 | 36.65 | 36.65 | 31.71 | 31.71 | 31.71 | 31.71 | 31.65 | 26.71 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.44 | 0.44 | 0.44 | 0.44 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.7 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.7 | 0.7 | 0.7 | 0.7 | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | 0.96 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About